Navigation Links
Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission
Date:12/8/2008

SAN DIEGO and INDIANAPOLIS, Dec. 8 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) is continuing with its review of the regulatory application for use of BYETTA(R) (exenatide) injection as stand-alone therapy (monotherapy) in people with type 2 diabetes who are not achieving acceptable blood sugar control. It is likely that this review will not be complete by the end of 2008, and may extend into 2009.

"Our discussions with the FDA continue to progress and we remain confident in the strength of our regulatory submission," said Orville G. Kolterman, senior vice president of research and development at Amylin Pharmaceuticals. "Importantly, we have not received any request for additional studies. We look forward to working closely with the agency as needed throughout the review process."

The regulatory application for use of BYETTA as monotherapy was submitted in the first quarter of 2008. The FDA is also reviewing several other BYETTA prescribing information updates submitted by the companies, including revision of safety language and conversion of physician labeling to the new standard format.

About BYETTA(R) (exenatide) injection

BYETTA is the first and only FDA-approved incretin mimetic for the treatment of type 2 diabetes. BYETTA exhibits many of the same effects as the human incretin hormone glucagon like peptide-1 (GLP-1). GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain. BYETTA is approved by the FDA for use by people with type 2 diabetes who are unsuccessful at controlling their blood sugar
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
4. Genentech/Roches Lucentis and Eli Lillys Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
5. Lillys CEO Calls for Reform of Nations Drug Safety System
6. Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
7. Lilly Grant to VA Will Enhance Services for Returning Combat Veterans
8. Lilly Delivers Strong Third-Quarter Results
9. Lilly and MacroGenics Announce Licensing and Collaboration Agreement
10. Eli Lilly and Company Aids California Recovery Effort
11. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... Vasectomy was associated with a small increased risk of ... lethal prostate cancer according to a new study from ... that the association remained even among men who received ... cancer cannot be explained by diagnostic bias. It is ... look at the link between vasectomy and prostate cancer. ...
(Date:7/9/2014)... of signals active in almost all types of cancer ... and may help fuel a tumour,s uncontrolled growth, new ... Research, London, identified a molecular trigger responsible for ratcheting ... cellular factory that makes the building blocks cancer cells ... TOR signalling pathway, called SREBP, controls the flow of ...
(Date:7/9/2014)... research into the metabolism of stromal support cells and ... of these cell types in the development of diseases ... conditions and cancer. That was the conclusion of a ... in the leading journal Nature . , Prof. ... wake-up call. The metabolism of cancer cells has been ...
(Date:7/9/2014)... drug users in Russia might contribute to HIV ... conducted by researchers from Boston University Schools of ... Petersburg Pavlov State University, sought to discover the ... of a cohort of HIV-positive people with lifetime ... arrested by police were more likely to share ...
(Date:7/9/2014)... news release is available in French . ... factors in 14 year old teens, including brain structure and ... 70% accuracy who will go on to develop binge drinking ... of conscientiousness, and other variables such as life events and ... of binge drinking. Whether or not the child had ...
Breaking Medicine News(10 mins):Health News:Vasectomy may increase risk of aggressive prostate cancer 2Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Wake-up call for more research into cell metabolism 2Health News:BU researchers relate arrests with HIV risk environment 2Health News:What drives a child to abuse alcohol? 2
... Academy of Ophthalmology and the Texas Ophthalmological, Association Remind Parents and ... Eyewear for Youth Sports and Back-to-School ... when an errant paintball smashed into his left eye and sent ... "I remember being very dizzy and I couldn,t stop vomiting," ...
... WASHINGTON, Sept. 1 /PRNewswire-USNewswire/-- Service Employees,International Union (SEIU) ... RN, issued the following statement regarding the work,being ... country in anticipation of,the health impacts of Hurricane ... the Gulf Coast, leaders of the Nurse,Alliance of ...
... Israel, Aug. 31 Elbit Imaging Ltd.,(Nasdaq: EMITF ... for the,second quarter of 2008., Profit for the ... US$ 16.7 million) of which profit of NIS 15.8 ... holders of,the Company and NIS 40.3 million (approximately US$ ...
... WASHINGTON, Aug. 31 As mandatory evacuations are ... is starting to receive,evacuees in shelters throughout the Gulf ... states: Alabama, Mississippi, Louisiana and Texas.,Everyone in the path ... officials,and heed evacuation orders when instructed to do so; ...
... Spanish . , The brain is the ... a complex, orchestrated manner that is related to the activation ... cognitive and emotional processes. It is the brain which finally ... stressful for us, and which regulates the stress responses that ...
... HAMILTON August 31, 2008 -- An international study ... medication used to lower blood pressure, reduced the outcome ... who are unable to tolerate a widely available and ... Teo, professors in the Michael G. DeGroote School of ...
Cached Medicine News:Health News:Keep Eyes Safely On The Ball 2Health News:Keep Eyes Safely On The Ball 3Health News:Nurse Alliance of SEIU Healthcare Mobilizing RNs and Medical Supplies to Gulf Coast Areas in Advance of Hurricane Gustav 2Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 2Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 3Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 4Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 5Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 6Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 7Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 8Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 9Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 10Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 11Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 12Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 13Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 14Health News:American Red Cross Relief Efforts Underway for Gustav 2Health News:Neurogenesis in the adult brain: The association with stress and depression 2Health News:Neurogenesis in the adult brain: The association with stress and depression 3Health News:Neurogenesis in the adult brain: The association with stress and depression 4Health News:Neurogenesis in the adult brain: The association with stress and depression 5Health News:Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke 2
(Date:1/15/2014)...  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the ... Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... in order to treat dental impairments, for tooth restoration ...
(Date:1/15/2014)... AARP Foundation today announced it has established a ... severe cold weather that has gripped much of the nation. ... need; so to support these emergency relief efforts AARP and ... could mean up to $500,000 in aid. The matching program ...
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
BD Vacutainer Citrate Tubes with 3.2% buffered sodium citrate solution are used for routine coagulation studies....
... Cross-match tubes are available ... serum tube contains a clotting ... cross-match tests where serum is ... EDTA cross-match tube is suitable ...
... tubes are available in two ... contains a clotting activator and ... where serum is required for ... tube is suitable where the ...
Inquire...
Medicine Products: